Your session is about to expire
← Back to Search
Speech Language Therapy + Digital Storybook for Childhood Hearing Loss
N/A
Waitlist Available
Led By Prasanth Pattisapu, MD
Research Sponsored by Prashant Malhotra
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Bilateral Sensorineural or mixed hearing loss at least (PTA≥30dB)
Male and female children ages 3.0-5.11 (5 years and 11 months) at time of initial assessment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12- month intervention period
Awards & highlights
Study Summary
This trial will compare the effects of adding a digital storybook intervention to in-person speech-language therapy for young children who are deaf or hard of hearing.
Who is the study for?
This trial is for children aged 3 to nearly 6 with bilateral sensorineural or mixed hearing loss, including auditory neuropathy in both ears. It's not suitable for kids where English isn't the primary language or those who score more than 2 standard deviations from normal on a specific language test (CELF-P3).Check my eligibility
What is being tested?
The study compares traditional in-person speech-language therapy with and without the addition of a digital storybook platform called 'Hear Me Read' to see if it improves vocabulary, speech, language, and literacy in young children with hearing loss.See study design
What are the potential side effects?
Since this trial involves educational interventions like speech therapy and digital applications rather than medical treatments, there are no typical side effects as one would expect from medication. However, individual experiences may vary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have hearing loss in both ears.
Select...
My child is between 3 and 5 years old.
Select...
I have hearing loss in both ears due to nerve damage.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12- month intervention period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12- month intervention period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical Evaluation of Language Fundamentals Preschool- 3 and Indices: Expressive Language Index
Clinical Evaluation of Language Fundamentals Preschool- 3 and Indices: Receptive Language Index
Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Basic Concepts
+8 moreSecondary outcome measures
Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Phonological Awareness
Clinical Evaluation of Language Fundamentals Preschool- 3 and subtests: Preliteracy Rating Scale
Clinical Evaluation of Language Fundamentals Preschool-3 Index: Early Literacy Index
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Speech Language Therapy + Digital PhaseExperimental Treatment2 Interventions
Children who are deaf/hard of hearing will receive standard of care speech and language therapy with a speech language pathologist with the addition of the digital app named, Hear Me Read, that will be used to achieve reading, speech and language goals through interactive digital storybook reading. Reading time is prescribed 20 min, 3x/week.
Group II: Speech Language TherapyActive Control1 Intervention
Children who are deaf/hard of hearing will receive standard of care speech and language therapy with a speech language pathologist. Reading time is prescribed 20 min, 3x/week.
Find a Location
Who is running the clinical trial?
Prashant MalhotraLead Sponsor
Prasanth PattisapuLead Sponsor
Clinical and Translational Intramural Funding Program from the Abigail Wexner Research InstituteUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your test scores are more than 2 standard deviations away from normal on the CELF-P3 test.English is not my first language.I have hearing loss in both ears.My child is between 3 and 5 years old.I have hearing loss in both ears due to nerve damage.
Research Study Groups:
This trial has the following groups:- Group 1: Speech Language Therapy
- Group 2: Speech Language Therapy + Digital Phase
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this medical study extend to individuals in their seventies?
"This clinical trial specifically seeks out children aged 3 to 5. In addition, there are 306 studies targeting minors and 763 trials designed for elderly patients."
Answered by AI
Are researchers actively looking for participants in this research project?
"Clinicaltrials.gov clarifies that this particular medical trial, which had its first posting on March 25th 2022 and was last edited on September 20th 2022, is not presently enrolling participants. However, there are 1110 other trials currently recruiting patients worldwide."
Answered by AI
Do I meet the criteria for enrollment in this trial?
"Participants aged between 3 and 5 years old with the support of speech therapy are eligible to join this trial. A total of 50 patients will be selected in the experiment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger